Wrinkles are the result of a range of complex biological mechanisms associated with skin ageing. Over time, fibroblasts, the cells responsible for synthesising collagen, elastin and glycosaminoglycans, slow down their activity. The skin then loses density, firmness and elasticity. Added to this are oxidation of the dermis’s structural proteins, collagen glycation and decreased sebum production, which compromise cellular cohesion and the skin’s capacity to regenerate. These intrinsic processes are compounded by extrinsic factors, such as exposure to the sun, which accounts for nearly 80% of visible skin ageing in phototypes fair, but also to tobacco and to pollution, which accelerate wrinkle formation due to oxidative stress and the chronic inflammation they provoke.
Many treatments are now capable of diminishing the appearance of wrinkles, yet none can eradicate them entirely.
Injections of hyaluronic acid, for example, restore volume and firmness to the skin and help to compensate for the loss of dermal support proteins. However, these effects are temporary and require regular top-ups. Similarly, biomimetic peptides, such as argireline, have shown promising results in reducing wrinkle depth and improving skin texture. Their action relies on direct communication with skin cells: they mimic neurotransmitters to limit muscle contractions. These mechanisms offer a visible improvement, but not a total eradication of wrinkles.
For example, a clinical study assessed the efficacy of argireline on periorbital wrinkles in 60 participants. They were randomised to apply a 10% argireline emulsion or a placebo twice daily for four weeks. As shown in the photograph below, the participants’ wrinkles were reduced but not eliminated.